Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope: drug may delay relapse in rare amyloidosis

NCT ID NCT03618537

First seen Dec 29, 2025 · Last updated May 23, 2026 · Updated 21 times

Summary

This study tests whether the chemotherapy drug Ixazomib can help control AL amyloidosis, a rare disease where abnormal proteins build up in organs. Seventeen adults who completed initial therapy receive Ixazomib as maintenance to prevent or delay relapse. The goal is to see if this approach improves event-free survival, meaning longer time without organ progression or need for further treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AL AMYLOIDOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Commack

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester

    Harrison, New York, 10604, United States

  • Tufts Medical Center

    Boston, Massachusetts, 02111, United States

Conditions

Explore the condition pages connected to this study.